This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

JAMA. 2001;285:2486-2497.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) constitutes the National Cholesterol Education Program's (NCEP's) updated clinical guidelines for cholesterol testing and management. The full ATP III document is an evidence-based and extensively referenced report that provides the scientific rationale for the recommendations contained in the executive summary. ATP III builds on previous ATP reports and expands the indications for intensive cholesterol-lowering therapy in clinical practice. It should be noted that these guidelines are intended to inform, not replace, the physician's clinical judgment, which must ultimately determine the appropriate treatment for each individual.

BACKGROUND

The third ATP report updates the existing recommendations for clinical management of high blood cholesterol. The NCEP periodically produces ATP clinical updates as warranted by advances in . . . [Full Text of this Article]

LDL CHOLESTEROL: THE PRIMARY TARGET OF THERAPY

RISK ASSESSMENT: FIRST STEP IN RISK MANAGEMENT

Method of Risk Assessment: Counting Major Risk Factors and Estimating 10-Year CHD Risk

Role of Other Risk Factors in Risk Assessment

Metabolic Syndrome

The Link Between Risk Assessment and Cost-effectiveness

PRIMARY PREVENTION WITH LDL-LOWERING THERAPY

SECONDARY PREVENTION WITH LDL-LOWERING THERAPY

LDL-LOWERING THERAPY IN 3 RISK CATEGORIES

CHD and CHD Risk Equivalents

Multiple (2+) Risk Factors and 10-Year Risk of 20%

Multiple (2+) Risk Factors and a 10-Year Risk of 10%-20%

Multiple (2+) Risk Factors and a 10-Year Risk of <10%

0-1 Risk Factor

THERAPEUTIC LIFESTYLE CHANGES IN LDL-LOWERING THERAPY

DRUG THERAPY TO ACHIEVE LDL CHOLESTEROL GOALS

Secondary Prevention: Drug Therapy for CHD and CHD Risk Equivalents

LDL-Lowering Drug Therapy for Primary Prevention

BENEFIT BEYOND LDL LOWERING: THE METABOLIC SYNDROME AS A SECONDARY TARGET OF THERAPY

Management of Underlying Causes of the Metabolic Syndrome

Weight Control

Physical Activity

Specific Treatment of Lipid and Nonlipid Risk Factors

SPECIAL ISSUES

Management of Specific Dyslipidemias

Very High LDL Cholesterol (190 mg/dL)

Elevated Serum Triglycerides

Low HDL Cholesterol

Diabetic Dyslipidemia

Special Considerations for Different Population Groups

Middle-Aged Men (35-65 Years)

Women Aged 45-75 Years

Older Adults (Men 65 Years and Women 75 Years)

Younger Adults (Men 20-35 Years; Women 20-45 Years)

Racial and Ethnic Groups

ADHERENCE TO LDL-LOWERING THERAPY



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Guidelines for Diagnosis and Treatment of High Cholesterol
W. E. Feeman, Jr, Laura Ryan Caldwell, Douglas Iliff, Paul J. Rosch, Bruce L. Ring, Scott M. Grundy, and James I. Cleeman
JAMA. 2001;286(19):2400-2402.
EXTRACT | FULL TEXT  

Raloxifene and Risk of Cardiovascular Events
Dean F. Mayer, Elizabeth Barrett-Connor, Andreas Sashegyi, David A. Cox, and Kristine D. Harper
JAMA. 2002;288(1):42-43.
EXTRACT | FULL TEXT  

Definitions of the Metabolic Syndrome
Nigel Unwin
JAMA. 2003;289(10):1240.
EXTRACT | FULL TEXT  

Reducing the Risk of Stroke
Kamakshi Lakshminarayan and David C. Anderson
JAMA. 2003;289(15):1928.
EXTRACT | FULL TEXT  

Lipid-Lowering Therapy and Risk of Coronary Events
William C. Taylor
JAMA. 2003;289(16):2070.
EXTRACT | FULL TEXT  

The JNC 7 Hypertension Guidelines
Thomas G. Majernick and Nancy Madden
JAMA. 2003;290(10):1314.
EXTRACT | FULL TEXT  

Contribution of Periodontal Therapy on Individual Cardiovascular Risk Assessment
Francesco D’Aiuto and Maurizio S. Tonetti
Arch Intern Med. 2005;165(16):1920-1921.
EXTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Michael J. Pencina, Ramachandran S. Vasan, and Ralph B. D’Agostino, Sr
JAMA. 2007;298(2):175-176.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Updated Guidelines for Cholesterol Management
Michael S. Lauer and Phil B. Fontanarosa
JAMA. 2001;285(19):2508-2509.
EXTRACT | FULL TEXT  

May 16, 2001
JAMA. 2001;285(19):2521-2522.
EXTRACT | FULL TEXT  

Cholesterol and Atherosclerosis
JAMA. 2001;285(19):2536.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early histological changes in the kidney of people with morbid obesity
Goumenos et al.
Nephrol Dial Transplant 2009;24:3732-3738.
ABSTRACT | FULL TEXT  

Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS)
Jia et al.
Nephrol Dial Transplant 2009;24:3724-3731.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Florentin et al.
J CARDIOVASC PHARMACOL THER 2009;14:274-282.
ABSTRACT  

Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
Bo et al.
Am. J. Clin. Nutr. 2009;90:1502-1508.
ABSTRACT | FULL TEXT  

HDL as a Biomarker, Potential Therapeutic Target, and Therapy
Navab et al.
Diabetes 2009;58:2711-2717.
FULL TEXT  

Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
Kuk and Ardern
Diabetes Care 2009;32:2297-2299.
ABSTRACT | FULL TEXT  

The challenge of traditional Chinese medicines for allopathic practitioners
Karalliedde and Kappagoda
Am. J. Physiol. Heart Circ. Physiol. 2009;297:H1967-H1969.
FULL TEXT  

Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
Taylor et al.
NEJM 2009;361:2113-2122.
ABSTRACT | FULL TEXT  

The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study
Scuteri et al.
Eur Heart J 2009;0:ehp491v1-ehp491.
ABSTRACT | FULL TEXT  

Frailty, Body Mass Index, and Abdominal Obesity in Older People
Hubbard et al.
J Gerontol A Biol Sci Med Sci 2009;0:glp186v1-glp186.
ABSTRACT | FULL TEXT  

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:e13-e118.
FULL TEXT  

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2007 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:e169-e276.
FULL TEXT  

Risk factors for disability in older persons over 3-year follow-up
Balzi et al.
Age Ageing 2009;0:afp209v1-afp209.
ABSTRACT | FULL TEXT  

Biomarkers for Prediction of Cardiovascular Events--Reply
Melander et al.
JAMA 2009;302:2090-2090.
FULL TEXT  

Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration
JAMA 2009;302:1993-2000.
ABSTRACT | FULL TEXT  

Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors
Chen et al.
JCO 2009;27:5383-5389.
ABSTRACT | FULL TEXT  

Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score
Rubinshtein et al.
Eur Heart J 2009;0:ehp459v1-ehp459.
ABSTRACT | FULL TEXT  

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
Vassilatou et al.
Hum Reprod 2009;0:dep380v1-dep380.
ABSTRACT | FULL TEXT  

Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample
Volzke et al.
Eur J Endocrinol 2009;161:705-713.
ABSTRACT | FULL TEXT  

From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis
Klose et al.
Eur J Endocrinol 2009;161:S75-S83.
ABSTRACT | FULL TEXT  

Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III
Noble et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1206-1211.
ABSTRACT | FULL TEXT  

Lipid Profile Components and Risk of Ischemic Stroke: The Northern Manhattan Study (NOMAS)
Willey et al.
Arch Neurol 2009;66:1400-1406.
ABSTRACT | FULL TEXT  

How to Define Prehypertension in Diabetes/Metabolic Syndrome
Leibowitz and Grossman
Diabetes Care 2009;32:S275-S279.
FULL TEXT  

Shifting the Disease Management Paradigm From Glucose: What are the pros?
Stirban et al.
Diabetes Care 2009;32:S349-S352.
FULL TEXT  

Should All Diabetic Patients Be Treated With a Statin?
Kamari et al.
Diabetes Care 2009;32:S378-S383.
FULL TEXT  

Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No
Kyrou and Tsigos
Diabetes Care 2009;32:S403-S409.
FULL TEXT  

Hypertension, Diabetes, And Elevated Cholesterol Among Insured And Uninsured U.S. Adults
Wilper et al.
Health Aff (Millwood) 2009;28:w1151-w1159.
ABSTRACT | FULL TEXT  

The metabolic syndrome: common origins of a multifactorial disorder
Bruce and Byrne
Postgrad. Med. J. 2009;85:614-621.
ABSTRACT | FULL TEXT  

Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association
Urbina et al.
Hypertension 2009;54:919-950.
ABSTRACT | FULL TEXT  

Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer
van Waas et al.
Ann Oncol 2009;0:mdp414v1-mdp414.
ABSTRACT | FULL TEXT  

Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study
Rana et al.
Heart 2009;95:1682-1687.
ABSTRACT | FULL TEXT  

Medicare Spending for Previously Uninsured Adults
McWilliams et al.
ANN INTERN MED 2009;0:0000605-200912010-00149v1-E-149.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology
Potenza and Mechanick
Nutr Clin Pract 2009;24:560-577.
ABSTRACT | FULL TEXT  

Metabolic syndrome in Argentinean patients with systemic lupus erythematosus
Bellomio et al.
Lupus 2009;18:1019-1025.
ABSTRACT  

Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area
Ayturk et al.
Eur J Endocrinol 2009;161:599-605.
ABSTRACT | FULL TEXT  

Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Wennersberg et al.
Am. J. Clin. Nutr. 2009;90:960-968.
ABSTRACT | FULL TEXT  

Responses of Blood Lipids to Aerobic, Resistance, and Combined Aerobic With Resistance Exercise Training: A Systematic Review of Current Evidence
Tambalis et al.
ANGIOLOGY 2009;60:614-632.
ABSTRACT  

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
Sookoian et al.
J. Lipid Res. 2009;50:2111-2116.
ABSTRACT | FULL TEXT  

Creation of a Metabolic Monitoring Program for Second-Generation (Atypical) Antipsychotics
Reeves et al.
J Correct Health Care 2009;15:292-301.
ABSTRACT  

Prevalence of Diabetes Mellitus, Glycemic Control, and Associated Factors in a Malay Population in Singapore
Sabanayagam et al.
Asia Pac J Public Health 2009;21:385-398.
ABSTRACT  

A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly
Sucunza et al.
J. Clin. Endocrinol. Metab. 2009;94:3889-3896.
ABSTRACT | FULL TEXT  

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
van Kruijsdijk et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2569-2578.
ABSTRACT | FULL TEXT  

Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men
Chang et al.
Gut 2009;58:1419-1425.
ABSTRACT | FULL TEXT  

Heterogeneous Effects of Fructose on Blood Lipids in Individuals With Type 2 Diabetes: Systematic review and meta-analysis of experimental trials in humans
Sievenpiper et al.
Diabetes Care 2009;32:1930-1937.
ABSTRACT | FULL TEXT  

Homocysteine and Pulsatility Index of Cerebral Arteries
Lim et al.
Stroke 2009;40:3216-3220.
ABSTRACT | FULL TEXT  

Medical (Nonsurgical) Intervention Alone Is Now Best for Prevention of Stroke Associated With Asymptomatic Severe Carotid Stenosis: Results of a Systematic Review and Analysis
Abbott
Stroke 2009;40:e573-e583.
ABSTRACT | FULL TEXT  

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease.
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:1336-1363.
FULL TEXT  

Trends in the Prevalence of Low Risk Factor Burden for Cardiovascular Disease Among United States Adults
Ford et al.
Circulation 2009;120:1181-1188.
ABSTRACT | FULL TEXT  

ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association
WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:e100-e126.
FULL TEXT  

Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis
Park et al.
Nephrol Dial Transplant 2009;0:gfp498v1-gfp498.
ABSTRACT | FULL TEXT  

Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey
Yu et al.
Nephrol Dial Transplant 2009;0:gfp483v2-gfp483.
ABSTRACT | FULL TEXT  

Cardiovascular disease in adult and pediatric HIV/AIDS.
McDonald and Kaltman
J Am Coll Cardiol 2009;54:1185-1188.
FULL TEXT  

Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study
Conen et al.
Circulation 2009;120:1041-1047.
ABSTRACT | FULL TEXT  

Metabolic syndrome and cancer-related mortality among Korean men and women
Lee et al.
Ann Oncol 2009;0:mdp344v1-mdp344.
ABSTRACT | FULL TEXT  

Ethyl-eicosapentaenoic Acid Reduces Liver Lipids and Lowers Plasma Levels of Lipids in Mice Fed a High-fat Diet
NEMOTO et al.
In Vivo 2009;23:685-689.
ABSTRACT | FULL TEXT  

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events
Wong et al.
J Am Coll Cardiol Img 2009;2:1093-1099.
ABSTRACT | FULL TEXT  

Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome
Elder et al.
J. Lipid Res. 2009;50:1917-1926.
ABSTRACT | FULL TEXT  

Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD
Matthan et al.
J. Lipid Res. 2009;50:1927-1935.
ABSTRACT | FULL TEXT  

Traffic exposure and subclinical cardiovascular disease: is the association modified by socioeconomic characteristics of individuals and neighbourhoods? Results from a multilevel study in an urban region
Dragano et al.
Occup. Environ. Med. 2009;66:628-635.
ABSTRACT | FULL TEXT  

Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study
Chiodini et al.
J. Clin. Endocrinol. Metab. 2009;94:3207-3214.
ABSTRACT | FULL TEXT  

Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program
Smith et al.
Neurology 2009;73:709-716.
ABSTRACT | FULL TEXT  

Resistance exercise plus to aerobic activities is associated with better lipids' profile among healthy individuals: the ATTICA study
Pitsavos et al.
QJM 2009;102:609-616.
ABSTRACT | FULL TEXT  

The metabolic syndrome in older persons: a loosely defined constellation of symptoms or a distinct entity?
Morley and Sinclair
Age Ageing 2009;38:494-497.
FULL TEXT  

Statin therapy, muscle function and falls risk in community-dwelling older adults
Scott et al.
QJM 2009;102:625-633.
ABSTRACT | FULL TEXT  

Trends in 10-Year Predicted Risk of Cardiovascular Disease in the United States, 1976 to 2004
Lopez-Jimenez et al.
Circ Cardiovasc Qual Outcomes 2009;2:443-450.
ABSTRACT | FULL TEXT  

Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism?: A Population-Based Case-Control Study
Heit et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1399-1405.
ABSTRACT | FULL TEXT  

Hostility Is Associated With Visceral, But Not Subcutaneous, Fat in Middle-Aged African American and White Women
Lewis et al.
Psychosom. Med. 2009;71:733-740.
ABSTRACT | FULL TEXT  

Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome
Romero-Aleshire et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;297:R587-R592.
ABSTRACT | FULL TEXT  

Regarding REGARDS: Does Inflammation Explain Racial and Regional Differences in Cardiovascular Disease Risk?
Cook and Albert
Clin. Chem. 2009;55:1603-1605.
FULL TEXT  

Implications of Increased C-Reactive Protein for Cardiovascular Risk Stratification in Black and White Men and Women in the US
Cushman et al.
Clin. Chem. 2009;55:1627-1636.
ABSTRACT | FULL TEXT  

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie et al.
J Am Coll Cardiol 2009;54:585-594.
ABSTRACT | FULL TEXT  

Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study: The Multi-Ethnic Study of Atherosclerosis
Yeboah et al.
Circulation 2009;120:502-509.
ABSTRACT | FULL TEXT  

The Role of the Laboratory in the Diagnosis of the Metabolic Syndrome
Jialal
Am J Clin Pathol 2009;132:161-162.
FULL TEXT  

Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
Beddhu et al.
Nephrol Dial Transplant 2009;24:2482-2488.
ABSTRACT | FULL TEXT  

Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study
de Rooij et al.
Eur J Endocrinol 2009;161:223-230.
ABSTRACT | FULL TEXT  

Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults
Czernichow et al.
Am. J. Clin. Nutr. 2009;90:329-335.
ABSTRACT | FULL TEXT  

Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity
Rallidis et al.
Am. J. Clin. Nutr. 2009;90:263-268.
ABSTRACT | FULL TEXT  

Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project
Bartholomew et al.
Clin Trials 2009;6:329-343.
ABSTRACT  

Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)
Li et al.
J Clin Pharmacol 2009;49:947-956.
ABSTRACT | FULL TEXT  

Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes
Gatti et al.
Diabetes Care 2009;32:1550-1552.
ABSTRACT | FULL TEXT  

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
Martin et al.
Diabetes 2009;58:1887-1892.
ABSTRACT | FULL TEXT  

Long-term trends in use of and expenditures for cardiovascular medications in Canada
Jackevicius et al.
CMAJ 2009;181:E19-E28.
ABSTRACT | FULL TEXT  

Psychiatric Involvement in Obesity Treatment
Ruelaz
Focus 2009;7:311-316.
ABSTRACT | FULL TEXT  

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander et al.
JAMA 2009;302:49-57.
ABSTRACT | FULL TEXT  

Paradoxical fall in HDL cholesterol observed in a patient treated with rosiglitazone and pioglitazone
Saraf et al.
British Journal of Diabetes & Vascular Disease 2009;9:186-189.
 

Training improves the response in glucose flux to exercise in postmenopausal women
Zarins et al.
J. Appl. Physiol. 2009;107:90-97.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study
Shea et al.
J Am Med Inform Assoc 2009;16:446-456.
ABSTRACT | FULL TEXT